The Hidden Lipid World That Keeps Cilia Working

Cilia are the tiny, hair-like projections that decorate nearly every cell in the human body, and for decades researchers have treated them primarily as protein machines. A new review published in Advanced Science argues that this protein-centric view has obscured half the story. The ciliary membrane, a lipid bilayer continuous with the plasma membrane yet strikingly different in composition, emerges as a dynamic regulatory platform whose fatty building blocks govern everything from the construction of the organelle to the signaling pathways that pattern the embryo. When that lipid balance collapses, the consequences are a family of devastating genetic disorders known as ciliopathies, which strike the kidneys, eyes, brain, and skeleton.

The review, led by researchers including Peiwei Liu and supported by the National Natural Science Foundation of China, assembles evidence from mass spectrometry studies of isolated cilia in mammals and unicellular organisms to sketch the first broad map of ciliary membrane lipids. Primary cilia isolated from kidney-derived MDCK cells are enriched in cholesterol and its precursor desmosterol, apparently to reinforce membrane microdomains used for signal transduction. Motile cilia from porcine olfactory epithelium tell a different story: they lack cardiolipin, carry reduced amounts of phosphatidylethanolamine, and are enriched in sulfoglycosphingolipids, an adaptive profile thought to optimize the membrane for the mechanical stress of beating. In single-celled organisms the diversity is even more striking. The flagellar membrane of Trypanosoma brucei is rich in phosphatidylethanolamine, phosphatidylserine, ceramides, and sphingomyelin, while Chlamydomonas reinhardtii concentrates phytoceramide and ergosterol, lipids suited to photophysical processes and to ordered microdomains at the flagellar base.

Perhaps the most visually compelling finding concerns phosphoinositides, phosphorylated derivatives of phosphatidylinositol that form exquisitely organized rings within the cilium. Phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate localize to the transition zone, the molecular sieve at the ciliary base, where they occupy distinct subregions along the proximal-distal axis: PI(4,5)P2 sits closer to the basal body while PI(3,4,5)P3 occupies the distal portion. Phosphatidylinositol 4-phosphate, by contrast, is excluded from the transition zone and accumulates toward the ciliary tip. This polarized geography is not decorative. PI4P directly binds the C-terminus of the signaling protein Smoothened, driving the conformational change and phosphorylation required for Hedgehog pathway activation, one of the most conserved developmental signaling systems in animals. Cholesterol, meanwhile, can itself activate Smoothened through multiple binding domains, and its release from the receptor Patched 1 upon Hedgehog ligand binding is a central step in the cascade.

The review also confronts a stubborn technical controversy. Measurements of ciliary PI(4,5)P2 have produced conflicting results for years, with some studies detecting the lipid along the entire axoneme and others confining it strictly to the transition zone. The authors trace these discrepancies to permeabilization methods, microscopy techniques, and differences between antibodies and genetically encoded biosensors. Methanol fixation followed by confocal imaging spreads the signal along the axoneme, whereas Triton X-100 permeabilization or super-resolution STED microscopy restricts it to the transition zone. The field has not even agreed on whether low-level ciliary PI(4,5)P2 is physiological or pathological. The authors call for quantitative mass spectrometry, correlative light-electron microscopy, artificial intelligence-assisted artifact correction, and absolutely calibrated biosensors to settle the debate.

Beyond phosphoinositides, the review highlights cholesterol sequestration as a surprising regulatory mechanism. Using newly developed protein probes derived from bacterial toxins, researchers compared the ciliary membrane with the adjacent plasma membrane and found that the ratio of sphingomyelin to cholesterol is far higher in cilia, with accessible cholesterol present at extremely low levels. In other words, abundant sphingomyelin chelates cholesterol into a chemically inactive state. When sphingomyelin synthesis is inhibited, the trapped cholesterol is released and Hedgehog signaling is enhanced. This finding reframes the ciliary membrane as a buffered reservoir of sterol whose availability, not just abundance, controls signal output. Lipid rafts, the cholesterol- and sphingolipid-rich microdomains concentrated at the ciliary base, serve as platforms that gather GPI-anchored and acylated proteins, amplifying signaling, although the review notes that some ciliary proteins, such as adenylyl cyclase III and INPP5E, reach their destinations even when rafts are disrupted.

Lipids also act as molecular switches for building and dismantling the organelle itself. Phosphatidylserine on the trans-Golgi network recruits Rabin8 to initiate ciliary formation. Ceramides accumulate in an apical ceramide-enriched compartment above the basal body, and the enzyme SMPD4, which generates ceramide from sphingomyelin, is required for normal ciliary length; mutations in SMPD4 cause cilia shortening and are linked to cerebellar hypoplasia. Centrosomal PI4P must be cleared by the kinase PIPKIγ to allow recruitment of ciliogenesis factors such as TTBK2, while Golgi PI4P must be maintained by PI4KB to release Rab11a for delivery to centrioles. Distal PI(4,5)P2 controls ciliary length by regulating vesicle shedding at the tip. Even diet matters: a high-fat diet upregulates the enzyme SCD1, depleting palmitic acid needed for palmitoylation of ciliary proteins such as ARL13B and RAB8A in endothelial cells, while the same fatty acid accumulates in hypothalamic neurons, suppressing autophagy and shrinking their cilia. The microbiota-derived short-chain fatty acid butyrate, in contrast, promotes ciliogenesis in hunger-regulating neurons.

The clinical payoff of this basic science is substantial. In Bardet-Biedl syndrome, mutations in more than twenty genes disrupt the BBSome, a protein complex that balances lipid and protein traffic between the plasma membrane and the cilium. Loss of bbs1 in zebrafish photoreceptors causes free cholesterol to accumulate, and BBSome deficiency allows enzymes such as phospholipase D to build up inside cilia, altering their lipid composition. The authors propose a Fish Trap model in which the transition zone admits membrane proteins freely but blocks their exit, making BBSome-mediated export the only rescue route. In autosomal dominant polycystic kidney disease, cholesterol binding is essential for localizing the ion channel polycystin-2 to cilia, and the oxysterol 7β,27-dihydroxycholesterol gates the polycystin complex. Glycosphingolipids such as glucosylceramide and lactosylceramide are markedly elevated in polycystic kidneys. Zellweger syndrome, caused by peroxisome failure, starves cilia of cholesterol because peroxisomes normally ferry sterol along microtubules to the ciliary pocket, crippling Hedgehog signaling.

Phosphoinositide disorders complete the picture. Joubert syndrome, marked by the molar tooth sign on brain imaging, frequently stems from mutations in INPP5E, the enzyme that removes PI(4,5)P2 and PI(3,4,5)P3 from cilia. Without it, these lipids accumulate, disrupting the recruitment of the cargo adaptor TULP3 and derailing Hedgehog signaling. Intriguingly, different mutations in the same gene produce different diseases: catalytic-domain variants preserve ciliary targeting and cause Joubert syndrome, whereas C-terminal truncations destroy targeting but spare enzymatic activity, producing MORM syndrome with obesity and intellectual disability. Hydrolethalus syndrome, a lethal fetal ciliopathy, arises when mutant HYLS1 fails to activate PIPKIγ and clear centrosomal PI4P, simultaneously blocking ciliogenesis and Hedgehog signaling.

Therapeutically, the lipid angle is already yielding drugs. The glucosylceramide synthase inhibitor Genz-667161 alleviated obesity, retinal degeneration, and olfactory deficits in BBS mice while restoring ciliary structure and Hedgehog activity, and the related inhibitor Venglustat slowed cyst progression in polycystic kidney disease models. The approved MC4R agonist setmelanotide remains the core targeted therapy for BBS, though it requires dermatologic monitoring, and antisense oligonucleotides have restored protein expression in preclinical models of BBS16 splicing defects. A ketogenic diet improved kidney function in the KETO-ADPKD trial, and the PI3K inhibitor LY294002 partially rescued ciliary defects in zebrafish lacking inpp5e. The authors point to three frontiers: cryo-electron microscopy to resolve lipid-protein complexes at atomic resolution, deeper study of the cilia-metabolism axis linking ciliary dysfunction to obesity and dyslipidemia, and dynamic mapping of ciliary lipid rafts with spatial lipidomics and super-resolution imaging. What was once an afterthought of cilia biology, the membrane itself, is now the most promising therapeutic frontier in the field.

Subject of Research: Lipid homeostasis of the ciliary membrane and its role in cilia function and ciliopathies

Article Title: Ciliary Membrane Lipid Homeostasis in Health and Disease

Article References: Ciliary Membrane Lipid Homeostasis in Health and Disease. (n.d.). https://doi.org/10.1002/advs.77971

Image Credits: AI Generated

DOI: 10.1002/advs.77971

Keywords: cilia, ciliary membrane, lipids, cholesterol, phosphoinositides, ceramide, Hedgehog signaling, ciliopathies, Bardet-Biedl syndrome, polycystic kidney disease, Joubert syndrome, lipid rafts